Skip to main content

Table 1 Demographic, clinical, and laboratory characteristics of patients at baseline

From: A randomized trial of dihydroartemisinin–piperaquine versus artemether–lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali

Characteristics

AL

(n = 155)

DHA–PQ

(n = 155)

p values

Age group, years

 % < 5 years of age

21

23

0.6

 % 5–53 years of age

79

77

Gender categories

 % of female

47

46

0.6

 % of male

53

54

 % of fever

67

69

0.7

 % of anemia

42.7

41.1

0.7

 Median of parasitemia (IQR 25th and 75th percentiles)

Number of trophozoite/μl of blood

24,325 (9450–45,775)

21,200 (9280–38,875)

0.2